NewAmsterdam Pharma Company N.V. (NAMS) PE Ratio
NewAmsterdam Pharma Company N.V. (NAMS) PE ratio history, current valuation, and earnings analysis. Track price-to-earnings trends in Excel with MarketXLS.
PE Ratio Data
| Period | PE Ratio |
|---|---|
| 2022-12-31 | -31.72 |
| 2023-12-31 | -14.16 |
| 2024-12-31 | -11.89 |
| 2025-12-31 | -17.70 |
Get NewAmsterdam Pharma Company N.V. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =PERatio("NAMS")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | NAMS | $30.45 | +2.46% | 1.28M |
| 3 | ||||
| 4 | ||||
| 5 |